Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus
Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and invasive diseases. It is a significant cause of infectious disease morbidity and mortality worldwide, but no efficacious vaccine is cu...
Saved in:
Main Authors: | Shu Ki Tsoi, Pierre R. Smeesters, Hannah R. C. Frost, Paul Licciardi, Andrew C. Steer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/167089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant production platform for Group A Streptococcus glycoconjugate vaccines
by: Sowmya Ajay Castro, et al.
Published: (2025-01-01) -
The protective duration of Streptococcus agalactiae vaccine in Nile Tilapia for the prevention of streptococcosis
by: , Sukenda, et al.
Published: (2016-02-01) -
Development of a broad-spectrum epitope-based vaccine against Streptococcus pneumoniae.
by: Md Nahian, et al.
Published: (2025-01-01) -
Development of a broad-spectrum epitope-based vaccine against Streptococcus pneumoniae
by: Md. Nahian, et al.
Published: (2025-01-01) -
Parapharyngeal Abscesses Caused by Group G Streptococcus
by: Shori Tajima, et al.
Published: (2018-01-01)